<p>1, 6-O, O-Diacetylbritannilactone from Inula britannica Induces Anti-Tumor Effect on Oral Squamous Cell Carcinoma via miR-1247-3p/LXRα/ABCA1 Signaling</p>

Abstract

Introduction Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy affecting the oral cavity and is associated with severe morbidity and high mortality. 1, 6-O, O-Diacetylbritannilactone (OODBL) isolated from the medicinal herb of Inula britannica has various biological activities such as anti-inflammation and anti-cancer. However, the effect of OODBL on OSCC progression remains unclear. Here, we were interested in the function of OODBL in the development of OSCC. Methods The effect of OODBL on OSCC progression was analyzed by MTT assays, colony formation assays, transwell assays, apoptosis analysis, cell cycle analysis, and in vivo tumorigenicity analysis. The mechanism investigation was performed by qPCR assays, Western blot analysis, and luciferase reporter gene assays. Results We found that OODBL inhibits the proliferation of OSCC cells in vitro. Moreover, the migration and invasion were attenuated by OODBL treatment in the OSCC cells. OODBL arrested cells at the G0/G1 phase and induced cell apoptosis. OODBL was able to up-regulate the expression of LXRα, ABCA1, and ABCG1 in the system. In addition, OODBL activated LXRα/ABCA1 signaling by targeting miR-1247-3p. Furthermore, the expression levels of cytochrome c in the cytoplasm, cleaved caspase-9, and cleaved caspase-3 were dose-dependently reduced by OODBL. Besides, OODBL increased the expression ratio of Bax to Bcl-2. Moreover, OODBL repressed tumor growth of OSCC cells in vivo. Discussion Thus, we conclude that OODBL inhibits OSCC progression by modulating miR-1247-3p/LXRα/ABCA1 signaling. Our finding provides new insights into the mechanism by which OODBL exerts potent anti-tumor activity against OSCC. OODBL may be a potential anti-tumor candidate, providing a novel clinical treatment strategy of OSCC.

Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1

“…revealed that exosomal miR-3157-3p accelerated angiogenesis and metastasis in lung cancer. 26 miR-1247-3p serves as an oncogenic factor in many cancers, such as lung adenocarcinoma, 27 oral squamous cell carcinoma, 28 and bladder cancer. 13 Here, we discovered that miR-1247-3p was highly expressed in T24-exo and UM-UC-3-exo, and also highly detected in HUVECs after incubation with T24-exo and UM-UC-3-exo, suggesting the delivery of miR-1247-3p from exosomes to HUVECs.…”

Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers

“…These data imply that withaferin A could be a potent anticancer compound targeting LXRα, decreasing the expression of various angiogenesis and inflammatory markers and contributing to the therapeutics of HCC [ 110 ]. One study indicated that 1, 6-O, O-diacetylbritannilactone, extracted from Inula britannica , could inhibit the proliferation of oral squamous cell carcinoma (OSCC) cells and impair the migration and invasion of OSCC cells, mediated by miR-1247-3p/LXRα/ABCA1 signaling [ 111 ]. Yang et al suggested that lycopene could inhibit the proliferation of androgen-dependent human prostate tumor cells via the activation of the PPARγ/LXRα/ABCA1 signaling pathway [ 104 ].…”

miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance

“…MicroRNAs are small, non-coding RNAs, 20 to 24 bp in length, and act by interacting with the target mRNAs. It binds to the 3'-UTR and negatively regulates the target gene transcription [13][14][15]. It was shown in previous researches that in many cancers, miR-1247-3p was abnormally expressed and had various functions [16].…”